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In gonococci, the nonspecific antimicrobial resistance locus penB is known to be closely linked to loci
designated nmp that alter the Mr and antigenicity of the outer membrane porin protein I (P.I). We report that
after selection for the linked donor penB locus, occasional recombinants expressed P.I with some epitopes from
each parent. These hybrid P.1 antigens were stable on subculture and were transformed at a locus closely linked
to penB. The hybrid P.I antigens were detected with monoclonal antibodies in both coagglutination and
Western blot assays. The alterations of P.1 antigenicity may have resulted from recombination between
structural genes for P.I that are closely linked to penB.
Serological classification of Neisseria gonorrhoeae is
based at present on epitopes of the principal outer membrane
protein (P.I). In the original scheme, multiple serogroups
were delineated, of which the most common were sero-
groups WI and WII/Wlll (17). Analysis of peptide maps
suggests that P.Is from serogroups WI and WII/WIII are
distinctly different proteins (16), although each is a porin (F.
Greco, M. Blake, E. Gotschlich, and A. Mauro, Fed. Proc.
39:1813, 1980). Serogroup WI is now usually designated
P.IA, and WII/WIII is designated P.IB (16); each can be
further divided into multiple serovars on the basis of reac-
tions with a panel of monoclonal antibodies (9). Unlike
gonococcal pili or outer membrane protein II, which are
genetically highly unstable (5, 15), P.I does not undergo
spontaneous antigenic variation at high frequency.
Genetic loci designated nmp that affect the Mr and
antigenicity of gonococcal P.I are very closely linked to sac
(serum resistance) and penB (low-level nonspecific antibiotic
resistance) loci and less closely to genes determining resist-
ance to streptomycin (str) or spectinomycin (spc) (5). The
locus designated nmp-J results in the replacement of the
recipient P.I by the donor 39,000-molecular-weight P.I (3);
the serovar of the nmp-l-determined protein is P.IB-1 (un-
published data). The locus designated nmp-3 results in the
replacement of the recipient P.1 by the donor 39,000-
molecular-weight P.I, serovar P.IB-9 (19; unpublished data).
The nmp-2 locus results in the replacement of the recipient
P.1 by the donor 37,200-molecular-weight P.1 (4). The nmp4
locus determines a 36,500-molecular-weight serovar P.IA-1
species of P.I (unpublished data). It is not known whether
the nmp loci are structural genes for P.1; they could be
regulatory genes that alter the expression of the structural
genes, or they could be modifiers of the products of the
structural genes (3).
In this report we demonstrate that a small proportion of
recombinants selected for the closely linked donor penB
locus acquire a novel species of P.I with certain epitopes
from each parent. The results have important implications
for understanding the genetics of P.1 expression and possibly
for the mechanisms of variation of P.I in nature.
* Corresponding author.
MATERIALS AND METHODS
The gonococcal strains used in this study are listed in Table
1. Growth conditions and media were as previously described
(18). DNA was prepared by the method of Marmur (14).
Transformation experiments with piliated recipients were
performed by previously described methods (18), with
limiting concentrations of DNA. Transformants for penA4
were selected with 0.03 ,ug of penicillin G per ml,
transformants for mtr4 were selected with 0.5 p,g of
erythromycin per ml, and transformants for penB5 were
selected with 0.37 ,ug of penicillin G per ml. The MICs for
transformants were determined for penicillin G, tetracycline,
and erythromycin by the agar plate dilution technique (20).
Serotyping by coagglutination tests was performed with six
monoclonal antibodies against P.IA (WI-serogroup specific)
and six monoclonal antibodies against P.IB (WII/WIII-
serogroup specific) as described previously (21). The
monoclonal antibodies against P.IA were 4A12, 4G5, 2F12,
6D9, 5G9, and 5D1, and those against P.IB were 3C8, 1FS,
2D6, 2G2, 2D4, and 2H1. These reagents, already prepared
for use in serotyping, were obtained by courtesy of the
Centers for Disease Control, Atlanta, Ga.
Outer membrane preparations were made in lithium ace-
tate buffer by the method of Lambden and Heckels (11). P.I
was separated from other proteins by electrophoresis of
samples containing approximately 30 ,ug of protein on so-
dium dodecyl sulfate-10% polyacrylamide gels in a Laemmli
buffer system (10). Western blotting was performed by the
method of Burnette (1). The proteins were transferred from
the gel to nitrocellulose with 0.1% Zwittergent detergent 3-14
(Calbiochem-Behring) added to the transfer buffer (12). A
1:500 dilution of ascites fluid containing monoclonal antibod-
ies against P.I was allowed to bind to proteins on the
nitrocellulose following blocking of nitrocellulose with a 5%
bovine serum albumin solution. Monoclonal antibodies in
ascites were generously supplied by M. Tam (Genetic Sys-
tems). Radioiodinated staphylococcal protein A (specific
activity, 1 ,uCi/ml; Amersham Corp.) was added for radio-
graphic detection of bound antibody. The nitrocellulose was
exposed at -70°C to Kodak XR film with an intensifying
screen for 48 to 72 h.
One-dimensional peptide maps of P.I were generated by
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TABLE 1. N. gonorrhoeae strains
ProteinIMIC of
Strain Relevant genotype Proteinr penicillin Source or references rovar ~~~G(~j.g/ml)
FA19 Wild type, nmp4 IA-1 0.007 13
FA6140 penA4 mtr4 penBS nmp-5 IB-1 4.0 Local isolate
FA6142 penA4 mtr4 nmp-4 IA-1 0.25 Transformant, FA6140 x FA19
FA6143 penA4 mtr4 penB5 nmp-5 IB-1 0.5 Transformant, FA6140 x FA6142
FA6149 penA4 mtr4 penB5 nmp-6 IA/IB 0.5 Transformant, FA6140 x FA6142
F62 wild type, nmp-2 IB-7 0.007 13
FA6212 penA4 mtr4 nmp-2 IB-7 0.25 Transformant, FA6140 x F62
FA6213 penA4 mtr4 penB5 nmp-5 IB-1 1.0 Transformant, FA6140 x FA6212
FA6214 penA4 mtr4 penB5 nmp-7 IB-2 1.0 Transformant, FA6140 x FA6212
FA6215 penA4 mtr4 penBS nmp-8 IB-5 1.0 Transformant, FA6140 x FA6212
FA6216 penA4 mtr4 penB5 nmp-2 IB-7 1.0 Transformant, FA6140 x FA6212
the limited proteolysis technique of Cleveland et al. (6).
Bands corresponding to P.1 were excised from sodium
dodecyl sulfate-10% polyacrylamide gels and then digested
for 30 min with 1 ,ug of either Staphylococcus aureus V8
protease (Sigma Chemical Co.), chymotrypsin (Calbiochem-
Behring), or trypsin (Calbiochem-Behring) per ml. Peptide
maps were examined after being silver stained by the tech-
nique of Wray et al. (22).
RESULTS
An initial impetus for our experiments was interest in the
genetic basis of relatively high-level penicillin resistance
(penicillin G MIC, 2 to 4 ,ug/ml) in beta-lactamase-negative
gonococci (7). DNA from one such Penr strain, FA6140
(P.IB-1), was prepared and used in a series of transforma-
tions into Pens FA19 (P.IA-1) to increase its level of antibi-
otic resistance. Results demonstrated that Penr was due in
part to multiple chromosomal mutations very similar to
those described previously for somewhat less resistant iso-
lates (5, 20). FA6140 was shown to contain mutations
designated penA4 (penicillin resistance), mtr4 (nonspecific
multiple drug resistance), and penBS (nonspecific resist-
ance). Details of these experiments will be published else-
where.
Coagglutination assays of whole cells revealed no change
in recipient P.1 serovar in 30 penA4 transformants or 30
mtr4 transformants. When the donor penB5 locus was
introduced from FA6140 into a penA4 mtr4 transformant of
FA19 (FA6142), the P.1 serovar of the recipient changed in
each of 120 transformants characterized in three separate
transformations (Table 2). Of these, 119 acquired the P.IB-1
serovar pattern of the donor; FA6143 is representative. The
locus for the expression of P.IB-1 was designated nmp-5.
One transformant (FA6149) acquired an apparently hybrid
P.I with some donor P.IB epitopes and some recipient P.IA
epitopes; other donor and recipient epitopes were lost in
FA6149. Single-colony isolates of FA6149 all showed stable
expression of the new serovar, apparently excluding the
possibility of a mixed culture containing some cells with
P.IA and others with P.IB. When transforming DNA from
FA6149 was introduced into FA6142, each of 20 tested
penBS (Pen') transformants acquired a serovar identical to
that of FA6149. The locus determining the expression of the
P.IA/P.IB protein was designated nmp-6.
When FA6140 (P.IB-1) was introduced into a recipient
with a different P.IB serovar (F62; P.IB-7), similar results
were obtained. No change in recipient P.IB serovar was seen
by coagglutination with the introduction of either penA4 (21
transformants tested) or mtr4 (17 transformants tested).
When penB5 was introduced from FA6140 into the penA4
mtr4 derivative of F62 (FA6212), a concomitant serovar
change occurred in most transformants (Table 3). The most
common class (86.8%) acquired the donor P.IB-1 serovar;
FA6213 is representative of these. A few transformants (8 of
114) such as FA6216 retained the recipient P.IB-7 serovar.
Interestingly, two classes of novel P.IB transformants were
noted (FA6214 and FA6215). The serovars of FA6214
(P.IB-2) and FA6215 (P.IB-5) were stable during 3 months of
serial passage, and multiple single-colony isolates of each
gave identical serovar patterns. When transforming DNA
from FA6214 (P.IB-2) was introduced into FA6212 (P.IB-7),
23 of 28 penBS (Penr) transformants acquired the donor
P.IB-2 serovar; the remainder retained the serovar of the
recipient. Introduction of FA6215 (P.IB-5) DNA into
FA6212 resulted in 12 of 24 penB5 transformants with the
donor P.IB-5 serovar; the remainder retained the serovar of
the recipient. Loci for the expression of P.IB-2 and P.IB-5
were designated nmp-7 and nmp-8, respectively.
TABLE 2. Transformation of P.1 serovar specificity and appearance of a novel serovar in crosses between a P.IB donor and
P.IA recipient
Reactions with monoclonal antibodies against:
Strain P.IA P.IB Serovar Transformants
4A12 4G5 2F12 6D9 5G9 5D1 3C8 1F5 2D6 2G2 2D4 2H1 (120 tested)
Donor; FA6140 - - - - - - + + + - - + IB-1
Recipient; FA6142 + + + + + + - - - - - - IA-1
Transformanta; FA6149 - + + - - - + - + - - + IA/IB 0.8
Transformant; FA6143 - - - - - - + + + - - + IB-1 99.2
a Selection was made for the closely linked donor penB locus on plates containing 0.37 F.g of penicillin G per ml. Penr transformants were scored by
coagglutination reactions for the P.1 serovars. The linear order of the P.1 epitopes reactive with the monoclonal antibodies is unknown, and the listed order of
monoclonal antibodies bears no necessary relationship to the linear structures of P.1 in the various strains.
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Since the coagglutination reactions involved the use of
whole boiled bacterial cells, it seemed possible that the
altered patterns of reactivity with P.I-specific monoclonal
antibodies were not due to a change in P.1, but rather to a
change in the surrounding cell matrix. Accordingly, the
Western blot technique was used to test reactions of isolated
P.1 with the monoclonal antibodies. Outer membrane prep-
arations were made of the donor FA6140, the recipient
FA6142, and the P.IA/P.IB hybrid transformant, FA6149.
P.1 was separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, transferred to nitrocellulose, and al-
lowed to react with P.IB- or P.IA-specific monoclonal anti-
bodies. Of the six P.IB-specific monoclonal antibodies
tested, only 1F5 gave a positive signal by Western blot.
Monoclonal iF5 reacted with the donor FA6140 P.IB, but
not with FA6142 or FA6149 P.1, consistent with the coag-
glutination results (data not shown). Of the P.IA-specific
antibodies, 4A12 and 5D1 were poorly or not reactive by
Western blot against the P.IA recipient (FA6142) and were
not tested further. Antibodies 6D9 and 5G9, which reacted in
coagglutination tests with FA6142 (P.IA) but not FA6149
(P.IA/P.IB hybrid), gave identical results by Western blot
(Fig. 1). Monoclonal antibody 4G5, which reacted with both
recipient FA6142 and recombinant FA6149 by coagglutina-
tion, also reacted in immunoblots with the P.I of each of
these strains, but not with the donor FA6140 P.IB. These
results indicated that the P.1 protein of the P.IA/P.IB hybrid
FA6149 was indeed structurally altered, having lost two of
the three epitopes detected by these antibodies, while retain-
ing the third. The result with monoclonal antibody 2F12 was
more complicated, since membranes of the P.IB donor
FA6140 contained a band of lower Mr than P.IB that bound
2F12; this is in contrast to the coagglutination results, in
which FA6140 did not react with this P.IA-specific mono-
clonal antibody. The P.IA recipient FA6142 and the
P.IA/P.IB hybrid (FA6149) both showed P.1 binding of this
antibody, although 2F12 bound to the P.IA/P.IB hybrid
protein relatively weakly. This may indicate that the struc-
tural alterations in the FA6149 P.1 lowered the affinity of the
2F12-epitope for its antibody. Small amounts of lower-
molecular-weight material binding 2F12 was also seen in
both FA6142 and FA6149 membranes. The relationship of
these 2F12-binding proteins to PIA is unclear at present.
Similar experiments were undertaken with the novel P.IB
recombinants that resulted from the cross between donor
FA6140 (P.IB-1) and recipient FA6212 (P.IB-7). Again, the
only P.IB-specific monoclonal antibody that reacted in
Western blots was 1F5. The results (Fig. 2) were identical
6D9 5G9 4G5 2F12





FIG. 1. Immunoblotting of gonococcal outer membrane proteins
with P.IA-specific monoclonal antibodies. The monoclonal antibody
used to probe each blot is designated at the top of the figure. For
each panel, the membranes were isolated from the following strains:
lane a, FA6140 (P.IB donor); lane b, FA6142 (PIA recipient); lane
c, transformant FA6149 (P.IA/P.IB hybrid).
with those found by coagglutination: donor strain FA6140
and recombinants FA6213 and FA6215 reacted with mono-
clonal antibody iF5 in immunoblots, but FA6214 and recip-
ient FA6212 did not. The immunoblotting results indicated
that the different reactions with monoclonal antibodies in
coagglutination reactions probably were not due to varied
exposure of common P.1 epitopes on the surface of the
transformed cells, but rather to intrinsic differences in P.A
epitopes in the various transformants.
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TABLE 3. Transformation of P.I serovar specificity and the
appearance of new serovars in crosses between parents differing in
P.IB serovar
Reactions with monoclonal % Trans-
Strain antibodies against P.IB Sero- formants
var (1 etd3C8 1F5 2D6 2G2 2D4 2H1 (114 tested)
Donor; FA6140 + + + - - + IB-1
Recipient; FA6212 - - + + - + IB-7
Transformanta; FA6213 + + + - - + IB-1 86.8
Transformant; FA6214 + - + - - + IB-2 1.8
Transformant; FA6215 - + + + - + IB-5 4.4
Transformant; FA6216 - - + + - + IB-7 7.0
a Selection was made for the closely linked donor penB locus on plates
containing 0.37 pLg of penicillin G per ml. Penr transformants were scored by
coagglutination reactions for their P.I serovars. All were unreactive with six
tested monoclonal antibodies with specificity for P.IA.
FIG. 2. Immunoblotting of gonococcal outer membrane proteins
with P.IB-specific monoclonal antibody 1F5. Donor strain FA6140 is
in lane a. Recipient strain FA6212 is in lane b. Transformants
FA6213, FA6215, and FA6214 are in lanes c through e, respectively.
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We attempted to identify structural differences in recom-
binant P.1 expressing novel epitopes by comparing one-
dimensional peptide maps of donor, recipient, and recombi-
nant P.I. For this experiment, we chose recombinant strain
FA6149 (P.IA/P.IB), its donor parent FA6140 (P.IB-1), and
its recipient parent FA6142 (P.IA-1), reasoning that differ-
ences in peptide maps might be most obvious in a hybrid P.1
expressing both P.IA and P.IB epitopes. The one-
dimensional limited proteolysis peptide map of P.I from
recombinant FA6149 was indistinguishable from that of P.I
from recipient parent FA6142; both were obviously different
from P.1 from donor parent FA6140 (results not shown).
Hence, possible chemical differences in P.I structure in the
recombinant were too subtle to be detected by this relatively
insensitive technique.
DISCUSSION
Cotransformation of a locus affecting P.1 with the intro-
duction of penB is not a new observation. According to
Cannon et al. (3), it would be expected in 98% of transform-
ants. Bygdeman et al. also found 100% cotransformation
between a locus for low-level nonspecific antimicrobial
resistance and P.1 serogroup specificity (2). It was therefore
not surprising that the vast majority ofpenB5 transformants
of FA6142 (P.IA-1) and FA6212 (P.IB-7) acquired a serovar
pattern identical to that of donor FA6140 (P.IB-1). Of the
remaining transformants, a few retained the serovar of the
recipient. The cotransformation frequency between penB5
and nmp-5 locus affecting P.I expression was much higher
when FA6142 rather than FA6212 was the recipient; the
reasons for this are not clear. Although the present experi-
ments actually never separated the penBS (Penr) and nmp-5
(P.1) loci when FA6142 was the recipient, previous experi-
ments involving the use of sheared transforming DNA con-
taining the nmp-J locus and a recipient strain closely related
to FA6142 apparently did so, based on the Mr of P.1 (3).
Some transformants acquired unique serovar patterns,
including reactive epitopes from both parents. The new P.1
serovars were seen both in crosses between strains with
different antigenic forms of P.IB (7 of 114) and in crosses of
P.IB and P.IA strains (1 of 120). The P.IB/P.IA hybrid is
apparently very uncommon in nature. The only report of
such a strain is from Knapp et al. (9), who reported seeing 2
strains of 1,433 naturally occurring isolates from 12 different
countries which reacted with one P.IB reagent (iF5) and one
P.IA reagent (4G5). The reactivity with 4G5 was lost on
subculture, and peptide mapping demonstrated that the P.1
molecule belonged to the P.IB type (J. Knapp, personal
communication). The P.IA/P.IB hybrid FA6149 found as a
recombinant in this study was unlike that reported by Knapp
et al. in that it was stable on subculture and showed
reactivity of two P.IA epitopes (4G5 and 2F12) in addition to
reactivity of three P.IB epitopes (3C8, 2D6, and 2H1).
Recently, we identified another P.IA/P.IB hybrid among
transformants constructed in this laboratory during earlier
studies of the genetics of gonococcal serum resistance (4).
Using a str-7 P.IB-7 serum sensitive strain FA610 as donor
and str+ P.IA-1 serum-resistant strain FA19 as recipient, we
selected a str-7 serum-sensitive transformant (FA628) that
acquired a unique serovar pattern with reactivity to four
P.IA epitopes (4A12, 4G5, 2F12, 6D9) and one P.IB epitope
(2D6) (19; unpublished data). The formation of donor-
recipient P.1 hybrids was not appreciated previously because
of the lack of the P.I monoclonal antibodies for serotyping.
Earlier studies that involved the use of migration of P.I in
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
for identification of donor or recipient P.I concluded that the
nmp and sac (serum sensitivity) loci were closely linked but
separable (4). The present result does not invalidate the
former conclusion, but further analysis of the genetics of
serum sensitivity and P.1 structure by using P.1 monoclonal
antibodies appears warranted.
The occurrence of apparent P.1 recombinants such as
FA6149, FA6214, and FA6215 with epitopes from both the
donor and the recipient strengthens but does not prove the
hypothesis that the nmp loci are actually P.1 structural
gene(s). If structural genes for P.1 (e.g., nmp) were closely
linked to penB, selection for penB might be expected to
result occasionally in intragenic recombinants of the nmp
loci. Our results are consistent with the hypothesis that
structural genes for P.IA and P.IB are closely linked to each
other and to the penB locus. However, more work must be
done to firmly answer these questions, including more com-
plete analysis of the chemical structures of the parental and
hybrid P.I molecules and molecular cloning and sequencing
of DNA in the nmp-penB region.
It is possible that the close linkage between loci such as
penBS and the nmp loci affecting P.I antigenicity contributes
indirectly to the variation of P.1 in nature. Selection by
antibiotic pressures for in vivo penB transformants might
occasionally give rise to novel P.1 recombinants of the type
observed in this report. There is reason to believe that
gonococci undergo transformation in vivo (5, 8).
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